Document is current
Any future updates will be listed below
-
Authors
Wang, Zhenghang
Wang, Xinyu
Xu, Yu
Li, Jian
Zhang, Xiaotian
Peng, Zhi
Hu, Yajie
Zhao, Xinya
Dong, Kun
Zhang, Bei
Gao, Chan
Zhao, Xiaochen
Chen, Hui
Cai, Jinping
Bai, Yuezong
Sun, Yu
Shen, Lin
-
Funding
Funding for this research was provided by:
National Key Research and Development Program of China (2017YFC1308900)
Major Program of National Natural Science Foundation of China (91959205)
Beijing Natural Science Foundation (No. 7224323)
- License Information
-
More Information
Article History
Received: 8 October 2021
Accepted: 9 March 2022
First Online: 21 April 2022
Declarations
:
: Human samples and clinical data were collected and used in accordance with the principles of the Declaration of Helsinki and approved by the Ethics committee of Peking University Cancer Hospital. All participants provided written informed consents. This report followed the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.
: Not applicable.
: Yu Xu, Bei Zhang, Chan Gao, Hui Chen, Xiaochen Zhao, and Jinping Cai are employees of the 3D Medicines Inc. Other authors declare no potential conflicts of interest.
